Ernst emphasized the strategic transformation of Tivic into a diversified therapeutics company, combining biologic and bioelectronic approaches to address immune dysregulation. This includes ...

Small-molecule inhibitors targeting viral proteins could serve as an effective alternative for controlling the spread of COVID-19 at both individual and community levels. In this vein, a recent study ...

Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...

Adma Biologics (ADMA) shares soared 10.2% in the last trading session to close at $20.61. The move was backed by solid volume with far more shares changing hands than in a normal session. This ...

The database, which Cruz recently released, shows a full list of over 3,400 NSF grants, awarded under the Biden ...

Dr. Reddy’s Laboratories RDY and partner, Alvotech ALVO, announced the FDA’s acceptance of a regulatory filing, seeking the ...

Dr. Reddy’s Laboratories (RDY) and Alvotech (ALVO) announced that the U.S. FDA has accepted a Biologic License Application submission for AVT03. Read more here.

Significant progress was made in 2024, including refining the Phase 3 program to accelerate rilparencel’s path to market in the U.S., the release ...

Cadillac has finally received its official approval to join the 2026 Formula 1 grid, ending a year-long drama that started when General Motors and Andretti Global's application was initially ...

Ashley holds a bachelor's degree in multimedia journalism from Florida Atlantic University. If you’ve encountered offers for guaranteed approval credit cards with no deposit and thought it was hype, ...

HONG KONG, March 6 (Reuters) - Chinese tea chain Chagee has received approval from Beijing to list on Nasdaq in the U.S., adding to Chinese consumer brands that have been looking to raise funds ...

Main outcomes include (1) treatment effectiveness, based on: adherence, adding or switching biologic or PDE4, addition of new non-biologic disease-modifying antirheumatic drug, increase in biologic or ...